Publications by authors named "Anton Bom"

Claim this Profile
S
Sugammadex reverses neuromuscular block induced by 3-desacetyl-vecuronium, an active metabolite of vecuronium, in the anaesthetised rhesus monkey.
Lonneke M Staals, Jan van Egmond, Jacques J Driessen, Hans D de Boer, Francien van de Pol, Anton H Bom

Eur J Anaesthesiol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of rocuronium-induced neuromuscular block by sugammadex is independent of renal perfusion in anesthetized cats.
Lonneke M Staals, Hans D de Boer, Jan van Egmond, Frank Hope, Francien van de Pol, Anton H Bom

J Anesth· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical pharmacology of sugammadex.
Anton Bom, Frank Hope, Samantha Rutherford, Karen Thomson

J Crit Care· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective relaxant binding agents for reversal of neuromuscular blockade.
Anton Bom, Ola Epemolu, Frank Hope, Samantha Rutherford, Karen Thomson

Curr Opin Pharmacol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties.
Ronald Palin, Anton Bom, John K Clark, Louise Evans, Helen Feilden

Bioorg Med Chem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys.
Hans D de Boer, Jan van Egmond, Francien van de Pol, Anton Bom, Leo H D J Booij

Anesthesiology· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969.
Ola Epemolu, Anton Bom, Frank Hope, Rona Mason

Anesthesiology· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New approaches to reversal of neuromuscular block.
Anton Bom, John K Clark, Ronald Palin

Curr Opin Drug Discov Devel· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-O-substituted cyclodextrins as reversal agents for the neuromuscular blocker rocuronium bromide.
Gary J Tarver, Simon J A Grove, Kirsteen Buchanan, Anton Bom, Andrew Cooke

Bioorg Med Chem· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships.
Julia M Adam, D Jonathan Bennett, Anton Bom, John K Clark, Helen Feilden

J Med Chem· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host.
Anton Bom, Mark Bradley, Ken Cameron, John K Clark, Jan Van Egmond

Angew Chem Int Ed Engl· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis